Journey Medical Corporation (DERM)
USD 4.71
(-2.48%)
USD 4.71
(-2.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.24 Million | -13.53 Million | -2.18 Million | 5.13 Million | 9.01 Million | -213.09 Million |
| Net Income | -3.85 Million | -29.62 Million | -43.99 Million | 5.28 Million | 3.62 Million | -221.54 Million |
| Depreciation & Amortization | 3.85 Million | 4.36 Million | 2.56 Million | 1.51 Million | 1.26 Million | 555 Thousand |
| Deferred income taxes | 1.91 Million | - | 1.56 Million | -335 Thousand | 69 Thousand | -194 Thousand |
| Stock-based compensation | 2.6 Million | 4.42 Million | 2.46 Million | 153 Thousand | 240 Thousand | 29.84 Million |
| Change in working capital | -1.65 Million | 6.18 Million | 14.7 Million | -2.23 Million | 3.46 Million | -154.4 Million |
| Other non-cash items | 2.37 Million | 1.11 Million | 20.51 Million | 747 Thousand | 355 Thousand | 132.64 Million |
| Investing Cash Flow | -5 Million | -20 Million | -10 Million | -1.2 Million | -2.4 Million | -13.22 Million |
| Investments in PPE | -5 Million | -20 Million | -10 Million | -1.2 Million | -2.4 Million | -616 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -319.94 Million |
| Sales/Maturities of investments | - | - | - | - | - | 363.32 Million |
| Other Investing Activities | -5 Million | -20 Million | -10 Million | -1.2 Million | - | -56 Million |
| Financing Cash Flow | -4.8 Million | 16.45 Million | 53.01 Million | -487 Thousand | -3.55 Million | 35.38 Million |
| Debt repayment | -9.41 Million | -7.86 Million | -11.48 Million | -500 Thousand | -4 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -371 Thousand | -1.55 Million | - | - | 2.14 Million |
| Common Stock Issuance | 4.61 Million | -371 Thousand | 32.53 Million | 13 Thousand | - | 2.14 Million |
| Other Financing Activities | -471 Thousand | 25.43 Million | 35.06 Million | -487 Thousand | 449 Thousand | 31.08 Million |
| Accounts receivables | 12.55 Million | -5.38 Million | 768 Thousand | -5.02 Million | -10.49 Million | -5.67 Million |
| Accounts payables | -18.63 Million | 14.34 Million | 21.71 Million | -152 Thousand | 1.14 Million | 823 Thousand |
| Inventory | 3.95 Million | 1.74 Million | -8.45 Million | -547 Thousand | -179 Thousand | -8.37 Million |
| Other working capital | 480 Thousand | -4.52 Million | 686 Thousand | 3.48 Million | 12.98 Million | -141.18 Million |
| Cash at beginning of period | 32 Million | 49.08 Million | 8.24 Million | 4.8 Million | 1.73 Million | 295.92 Million |
| Cash at end of period | 27.43 Million | 32 Million | 49.08 Million | 8.24 Million | 4.8 Million | 104.97 Million |
| Capital Expenditure | -5 Million | -20 Million | -10 Million | -1.2 Million | -2.4 Million | -616 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4.56 Million | -17.07 Million | 40.83 Million | 3.44 Million | 3.06 Million | -190.94 Million |
| Free Cash Flow | 240 Thousand | -33.53 Million | -12.18 Million | 3.93 Million | 6.61 Million | -213.71 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.36 Million | -10.44 Million | -3.85 Million | -2.14 Million | 16.78 Million | -8.36 Million |
| Depreciation & Amortization | 839 Thousand | 836 Thousand | 3.85 Million | 838 Thousand | 836 Thousand | 1.09 Million |
| Deferred income taxes | - | - | 1.91 Million | -19.47 Million | -82 Thousand | 3.59 Million |
| Stock-based compensation | 1.67 Million | 1.4 Million | 2.6 Million | 529 Thousand | 558 Thousand | 873 Thousand |
| Change in working capital | -4.53 Million | 3.11 Million | -1.65 Million | -15.68 Million | 411 Thousand | 6.42 Million |
| Other non-cash items | 4.15 Million | 906 Thousand | 2.37 Million | 19.51 Million | 235 Thousand | 357 Thousand |
| Investing Cash Flow | - | - | -5 Million | 5 Million | - | - |
| Investments in PPE | - | - | -5 Million | 5 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -5 Million | - | - | - |
| Financing Cash Flow | 5.03 Million | 1.63 Million | -4.8 Million | 19.11 Million | -10.97 Million | -13.08 Million |
| Debt repayment | -5 Million | - | -9.41 Million | -15.52 Million | -11 Million | -13 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 31 Thousand | 1.63 Million | 4.61 Million | 4.59 Million | 22 Thousand | 3000.00 |
| Other Financing Activities | 5.03 Million | 153 Thousand | -471 Thousand | -380 Thousand | 22 Thousand | -91 Thousand |
| Accounts receivables | -812 Thousand | 5.41 Million | 12.55 Million | -7.17 Million | 8.83 Million | 10.43 Million |
| Accounts payables | -677 Thousand | -2.8 Million | -18.63 Million | -10.91 Million | -3.6 Million | -11.88 Million |
| Inventory | 893 Thousand | -374 Thousand | 3.95 Million | 818 Thousand | 1.14 Million | 1.11 Million |
| Other working capital | -3.94 Million | 873 Thousand | 480 Thousand | 1.58 Million | -5.95 Million | 6.76 Million |
| Cash at beginning of period | 24.05 Million | 27.43 Million | 32 Million | 24.74 Million | 16.98 Million | 26.09 Million |
| Cash at end of period | 23.91 Million | 24.05 Million | 27.43 Million | 27.43 Million | 24.74 Million | 16.98 Million |
| Capital Expenditure | - | - | -5 Million | 5 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -145 Thousand | -3.38 Million | -4.56 Million | 2.69 Million | 7.76 Million | -9.11 Million |
| Free Cash Flow | -5.17 Million | -5.01 Million | 240 Thousand | -11.42 Million | 18.74 Million | 3.96 Million |
OEM-B
EWRK
7619
7199
NATPLY
SUEZF